JOSEPH L HERRING Insider Trading $LH LABORATORY CORP OF AMERICA HOLDINGS
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOSEPH L HERRING.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOSEPH L HERRING. JOSEPH L HERRING is CEO of Covance Drug Division in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and Director in HENRY SCHEIN INC ($HSIC) and Chairman and CEO in COVANCE INC ($CVD) and President and CEO in COVANCE INC ($CVD) and President and COO in COVANCE INC ($CVD) and Director in TEAM HEALTH HOLDINGS INC. ($TMH).
JOSEPH L HERRING in LABORATORY CORP OF AMERICA HOLDINGS
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of JOSEPH L HERRING: CEO of Covance Drug Division
Holdings: 10,404 shares
Current Value: $1,351,063
Latest Transaction: Aug 04 2015
$LH Market Capitalization: $13.45B
$LH Previous Close: $129.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOSEPH L HERRING in LABORATORY CORP OF AMERICA HOLDINGS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CVD, HSIC, LH, TMH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 04 2015 | LH | LABORATORY CORP OF ... | HERRING JOSEPH L | CEO of Covance Drug ... | Option Exercise | M | 0.00 | 19,990 | 0 | 0 | |
| Aug 04 2015 | LH | LABORATORY CORP OF ... | HERRING JOSEPH L | CEO of Covance Drug ... | Payment of Exercise | F | 127.29 | 9,586 | 1,220,202 | 10,404 | 20 K to 10.4 K (-47.95 %) |
| Aug 04 2015 | LH | LABORATORY CORP OF ... | HERRING JOSEPH L | CEO of Covance Drug ... | Buy | M | 0.00 | 19,990 | 0 | 19,990 | 0 to 20 K |
| Feb 27 2015 | LH | LABORATORY CORP OF ... | HERRING JOSEPH L | CEO of Covance Drug ... | Sell | S | 122.03 | 6,158 | 751,448 | 0 | 6.2 K to 0 (-100.00 %) |
| Feb 27 2015 | LH | LABORATORY CORP OF ... | HERRING JOSEPH L | CEO of Covance Drug ... | Sell | S | 121.56 | 30,718 | 3,733,982 | 6,158 | 36.9 K to 6.2 K (-83.30 %) |
| Feb 25 2015 | LH | LABORATORY CORP OF ... | HERRING JOSEPH L | CEO of Covance Drug ... | Option Exercise | A | 0.00 | 19,990 | 0 | 19,990 |
Page: 1